Equivital, the enterprise wearable technology company that offers human data insights and BodyCAP, the microelectronic physiological monitoring company have partnered to offer core temperature monitoring as part of a holistic physiological data capture, transmit and analysis solution.
Through the partnership, clinical research teams will now have a solution that seamlessly integrates BodyCAP’s core temperature monitoring with Equivital’s FDA and CE cleared multiparameter physiological sensors and solution.
This allows researchers to seamlessly gather multi‐parametric data from many people and for this to be presented in a format which is easy to analyse.
Benefits of partnership
The partnership allows for:
- A dedicated Equivital eViewer Performance monitor offering data for up to 8 subjects that also supports multiple core capsules per subject.
- Core body temperature analysis alongside eq02+ LifeMonitor physiological measurements for each subject.
- An optimised user flow for data analysis.
Authority comment
By partnering with BodyCAP, Equivital can ensure to collect essential data effectively
“I am excited, through this partnership, to offer our customers a wider range of physiological data for use in their studies in a single solution. Just under half of our research community require accurate temperature monitoring alongside cardiorespiratory and activity data.”
“By partnering with BodyCAP we are confident that we can provide a comprehensive offering, as well as a good supply chain, ensuring that studies can collect essential data as effectively as possible.” Anmol Sood, Equivital CEO.
Multiparameter physiological monitoring
“Equivital is a respected brand for multiparameter physiological monitoring in humans and we are happy to partner, providing an integrated offering with their medical grade products.
“We are pleased to expand the reach of our technology to researchers that want greater flexibility in number of subjects and types of data. We look forward to finding other ways of making this partnership effective for our valued researchers.” Sébastien Moussay, BodyCAP CEO
